(Q34663197)

3 August 2017

Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis (English)

1 reference

3 August 2017

1

Amy D Proal

0 references

Trevor Marshall

3

object named as

Trevor G Marshall

1 reference

3 August 2017

2

Paul J Albert

0 references

Inge A Lindseth

5

object named as

Inge A Lindseth

0 references

Greg P Blaney

4

object named as

Greg P Blaney

0 references

author name string

Amy D Proal

1

1 reference

3 August 2017

Greg P Blaney

4

1 reference

3 August 2017

Inge A Lindseth

5

1 reference

3 August 2017

1 July 2013

1 reference

3 August 2017

1 reference

3 August 2017

56

1 reference

3 August 2017

398-412

1 reference

3 August 2017

2-3

1 reference

https://scigraph.springernature.com/pub.10.1007/s12026-013-8413-z

3 August 2017

0 references

cites work

Role of infection and neurologic dysfunction in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Does blood of healthy subjects contain bacterial ribosomal DNA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Distinguishing protein-coding and noncoding genes in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Viruses in the faecal microbiota of monozygotic twins and their mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

A catalog of reference genomes from the human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Global diversity in the human salivary microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Bacterial invasion of vascular cell types: vascular infectology and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Cultivation of Enterobacter hormaechei from human atherosclerotic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Highlighting new phylogenetic specificities of Crohn's disease microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Toward defining the autoimmune microbiome for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Temperament and character profile of patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Substantial alterations of the cutaneous bacterial biota in psoriatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Personality variations in bronchial asthma; a study of forty patients: notes on the relationship to psychosis and the problem of measuring maturity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Childhood asthma after bacterial colonization of the airway in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Role of bacteria in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Microbiome and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Intestinal inflammation targets cancer-inducing activity of the microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Moving pictures of the human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Longitudinal study of the dynamics of vaginal microflora during two consecutive menstrual cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

High temporal and inter-individual variation detected in the human ileal microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Epstein-Barr virus protein EB2 stimulates cytoplasmic mRNA accumulation by counteracting the deleterious effects of SRp20 on viral mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Apoptosis in infectious disease: how bacteria interfere with the apoptotic apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Controlling the maturation of pathogen-containing vacuoles: a matter of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

The Legionella effector protein DrrA AMPylates the membrane traffic regulator Rab1b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Nocardia brasiliensis Modulates IFN-gamma, IL-10, and IL-12 cytokine production by macrophages from BALB/c Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Whole-body systems approaches for gut microbiota-targeted, preventive healthcare.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Expression systems of human β-defensins: vectors, purification and biological activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Antimicrobial peptides: old molecules with new ideas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Studies on tumor variability. V. In vivo and in vitro investigations on H10Z tumor lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Vitamin D metabolites as clinical markers in autoimmune and chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Vitamin D discovery outpaces FDA decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Dysregulation of the vitamin D nuclear receptor may contribute to the higher prevalence of some autoimmune diseases in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Neuroendocrine and immune contributors to fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Computational promoter analysis of mouse, rat and human antimicrobial peptide-coding genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Prediction of protein-protein interactions between human host and a pathogen and its application to three pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Viral infection can induce the production of autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Autoantibodies in nonautoimmune individuals during infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Neonatal Haemophilus influenzae infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Acquisition of Helicobacter pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Human papillomavirus DNA detected in breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Mode of delivery affects the bacterial community in the newborn gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Architectural design influences the diversity and structure of the built environment microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Bacterial community structure in the drinking water microbiome is governed by filtration processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Multidrug-resistant enterococci in animal meat and faeces and co-transfer of resistance from an Enterococcus durans to a human Enterococcus faecium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Rituximab-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Immunostimulation in the era of the metagenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Immune reconstitution inflammatory syndrome after highly active antiretroviral therapy: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: joint effect with vitamin D?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8413-Z

21 January 2018

Tackling the microbiome.

1 reference

12 December 2020

Expression profile of nuclear receptors upon Epstein -- Barr virus induced B cell transformation.

1 reference

12 December 2020

Donor-acquired sarcoidosis

1 reference

12 December 2020

Infectious mononucleosis: psychological symptoms during acute and subacute phases of illness

1 reference

12 December 2020

High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients

1 reference

12 December 2020

Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis

1 reference

12 December 2020

The mind-body-microbial continuum

1 reference

12 December 2020

Using a cDNA microarray to study cellular gene expression altered by Mycobacterium tuberculosis.

1 reference

12 December 2020

The human microbiome: at the interface of health and disease

1 reference

12 December 2020

IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome

1 reference

12 December 2020

["Masked" autoantibodies from the serum of healthy blood donors cross-reacting with DNA and bacterial lipopolysaccharides]

1 reference

12 December 2020

Gene expression profiles during in vivo human rhinovirus infection: insights into the host response

1 reference

12 December 2020

Systemic toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease

1 reference

12 December 2020

Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.

1 reference

12 December 2020

Bacterial infection and semen characteristics in infertile men

1 reference

12 December 2020

Hypoxia triggers the expression of human β defensin 2 and antimicrobial activity against Mycobacterium tuberculosis in human macrophages

1 reference

12 December 2020

Personality differences between inflammatory bowel disease patients and their healthy siblings

1 reference

12 December 2020

Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients.

1 reference

12 December 2020

The microbiome and rheumatoid arthritis

1 reference

12 December 2020

Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome.

1 reference

12 December 2020

10.1007/S12026-013-8413-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference